ClinicalTrials HQ

California Eye Specialists Medical Group, Inc.

California Eye Specialists Medical Group, Inc.

Pasadena, California, United States

4 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)diabetic macular edemaActive, not recruitingPhase 32026-09-18NCT06491914
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLEeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 32026-05-18NCT06996080
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 32026-05-18NCT06990399
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKWet Age-related Macular DegenerationActive, not recruitingPhase 32026-04-29NCT06556368